USE OF CISPLATIN IN COMBINATION WITH FOLIC ACID FOR INCREASING CISPLATIN EFFICACY

Details for Australian Patent Application No. 2003230048 (hide)

Owner ELI LILLY AND COMPANY

Inventors NIYIKIZA, Clet

Pub. Number AU-A-2003230048

PCT Number PCT/IB03/01715

PCT Pub. Number WO2003/094922

Priority 60/378,923 07.05.02 US

Filing date 1 May 2003

Wipo publication date 11 November 2003

International Classifications

A61K 031/519 - ortho- or peri-condensed with heterocyclic rings

A61K 033/24 Medicinal preparations containing inorganic active ingredients - Heavy metals

A61P 035/00 Antineoplastic agents

Event Publications

14 August 2003 Complete Application Filed

  Priority application(s): 60/378,923 07.05.02 US

15 January 2004 Application Open to Public Inspection

  Published as AU-A-2003230048

27 January 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

3 December 2009 Corrigenda

  Applications OPI - Name Index Under the name Eli Lilly And Company, Application No. 2003230048, under INID (43) correct the publication date to read 24.11.2003

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003230049-IMPROVEMENTS IN AND RELATING TO SPEAKER SYSTEMS

2003230047-A MULTIMERIC SELF-CLEAVING RIBOZYME CONSTRUCT